Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2006

View Archived Issues

CE Mark for Tag-It Cystic Fibrosis Kit

ActivBiotics and Metaphore Pharmaceuticals complete merger

Pharmacopeia earns milestone payment in Organon collaboration

New multidose study of Riquent planned in lupus patients

Studies show BioThrax plus antibiotics protect animals post anthrax exposure

Japanese licensing deal for Fentanyl Taifun

Corautus Genetics to support study of VEGF-2 in critical limb ischemia

Salix offers development update

Duloxetine 60 mg once daily found safe and effective in fibromyalgia patients

GE-81112 factor B: A novel prokaryotic-specific protein synthesis inhibitor

Human Genome Sciences receives milestone for GSK-716155 IND filing

Mylan and Forest sign nebivolol agreement

Ablynx and Centocor sign Nanobodies agreement

Phase IIa study of ATL-1102 restarts

Safety data review in phase III study of Intercell's Japanese encephalitis vaccine

Russian approvals for HER-2 Protein AutoVac vaccine phase II trial

Placebo group assumptions correct in phase IIb study of VLTS-934 in intermittent claudication

Novel orally active CB1 receptor inverse agonist decreases food intake in rodents

Novel orally active and in vivo effective p38alpha MAPK inhibitors from Novartis

FDA issues guidance to improve efficiency of earliest stages of clinical testing

Recent patents report novel therapeutic agents for anxiety, depression, etc.

Novel possible treatment options for cancer disclosed in patent literature

First launch for Dong-A erectile dysfunction therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...